Nov 14, 2022 04:03PM
Nov 14, 2022 04:03PM
Nov 14, 2022 04:03PM
Aug 9, 2022 04:02PM
Aug 9, 2022 04:02PM
Jul 27, 2022 08:00AM
Jul 27, 2022 08:00AM Neoleukin Therapeutics to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 9, 2022
May 16, 2022 08:00AM
May 16, 2022 08:00AM
May 9, 2022 04:05PM
May 9, 2022 04:05PM
Apr 13, 2022 10:00AM
Apr 13, 2022 10:00AM
Mar 15, 2022 08:00AM Neoleukin Therapeutics Announces Appointment of Donna Cochener as General Counsel
Mar 15, 2022 08:00AM
Mar 8, 2022 04:01PM
Mar 8, 2022 04:01PM
Mar 1, 2022 04:03PM
Mar 1, 2022 04:03PM
Feb 22, 2022 08:00AM
Feb 22, 2022 08:00AM Neoleukin Therapeutics to Host 2021 Financial Results Conference Call and Webcast on March 1, 2022
Feb 3, 2022 08:00AM
Feb 3, 2022 08:00AM
Jan 10, 2022 08:00AM
Jan 10, 2022 08:00AM
Jan 10, 2022 06:00AM
Jan 10, 2022 06:00AM
Dec 13, 2021 05:12AM Neoleukin Therapeutics (NLTX) Reports Preclinical Data Highlighting Activity of NL-201 in Hematologic Malignancies
Dec 11, 2021 05:30PM
Dec 11, 2021 05:30PM
Nov 12, 2021 07:05AM
Nov 12, 2021 07:05AM
Nov 9, 2021 08:00AM
Nov 9, 2021 08:00AM
Nov 4, 2021 04:05PM Neoleukin Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Update
Nov 4, 2021 04:05PM
Oct 1, 2021 09:07AM
Oct 1, 2021 09:07AM
Sep 29, 2021 08:05AM
Sep 29, 2021 08:00AM
Sep 29, 2021 08:00AM
Sep 9, 2021 08:00AM Neoleukin Therapeutics Announces Appointment of Bill Arthur, Ph.D., as Vice President and Head of Research
Sep 9, 2021 08:00AM
Sep 7, 2021 08:00AM
Sep 7, 2021 08:00AM
Aug 5, 2021 04:05PM
Aug 5, 2021 04:05PM
Aug 4, 2021 08:00AM
Aug 4, 2021 08:00AM Neoleukin Therapeutics to Participate in Canaccord Genuity 41st Annual Growth Conference
May 26, 2021 08:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All